Avantor (AVTR) Stock Forecast & Price Target

$21.11 -0.87 (-3.96%)

(As of 05:30 PM ET)

Avantor - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 13 Analyst Ratings

Sell
0

Hold
2

Buy
11

Based on 13 Wall Street analysts who have issued ratings for Avantor in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 13 analysts, 2 have given a hold rating, and 11 have given a buy rating for AVTR.

Consensus Price Target

$27.69
31.18% Upside

According to the 13 analysts' twelve-month price targets for Avantor, the average price target is $27.69. The highest price target for AVTR is $34.00, while the lowest price target for AVTR is $23.00. The average price target represents a forecasted upside of 31.18% from the current price of $21.11.

Get the Latest News and Ratings for AVTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Avantor and its competitors.

AVTR Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	11 Buy rating(s)	12 Buy rating(s)	12 Buy rating(s)	10 Buy rating(s)
Hold	2 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$27.69	$27.57	$27.40	$24.58
Forecasted Upside	31.18% Upside	36.63% Upside	-1.08% Downside	6.46% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

This Crypto Is Set to Explode in December (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

AVTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AVTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Avantor Stock vs. The Competition

Type	Avantor	Medical Companies	S&P 500
Consensus Rating Score	2.85	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	26.51% Upside	27,804.18% Upside	11.94% Upside
News Sentiment Rating	Positive News See Recent AVTR News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/28/2024	Wells Fargo & Company 3 of 5 stars	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$30.00 ➝ $28.00	+23.78%
10/28/2024	Robert W. Baird 2 of 5 stars		Lower Target	Outperform ➝ Outperform	$27.00 ➝ $26.00	+15.92%
10/25/2024	Barclays 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$28.00 ➝ $25.00	+11.46%
10/8/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$30.00 ➝ $29.00	+16.70%
9/26/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Outperform	$34.00 ➝ $34.00	+29.92%
7/29/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$28.00 ➝ $29.00	+10.81%
Get the Latest News and Ratings for AVTR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.
7/29/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$28.00 ➝ $31.00	+18.32%
7/29/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$27.00 ➝ $28.00	+9.37%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$30.00 ➝ $23.00	+10.13%
7/2/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$28.00 ➝ $27.00	+30.88%
4/18/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$23.00 ➝ $25.00	+2.54%
2/15/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$26.00 ➝ $29.00	+18.08%
1/26/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$22.50 ➝ $26.00	+18.51%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
12/7/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$23.00 ➝ $26.00	+23.99%
9/28/2023	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform	$22.00	+5.90%
7/31/2023	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Larew Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
7/30/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy	$27.00 ➝ $24.00	+12.78%
5/1/2023	888 Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Maintains

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 09:09 PM ET.

AVTR Forecast - Frequently Asked Questions

: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Avantor is $27.69, with a high forecast of $34.00 and a low forecast of $23.00.
: 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 2 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AVTR shares.
: According to analysts, Avantor's stock has a predicted upside of 31.18% based on their 12-month stock forecasts.
: Avantor has been rated by research analysts at Barclays, Robert W. Baird, Royal Bank of Canada, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Avantor more than other "medical" companies. The consensus rating score for Avantor is 2.85 while the average consensus rating score for "medical" companies is 2.81. Learn more on how AVTR compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol

This page (NYSE:AVTR) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Avantor (AVTR) Stock Forecast & Price Target